DUPILUMAB (Dupixent®)

Clinical Indication

Type 2 inflammation in asthma inadequately controlled by high dose ICS


As part of FOC scheme

Date of classification

October 2020


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.